🇺🇸 FDA
Patent

US 11000600

Exon skipping oligomer conjugates for muscular dystrophy

granted A61KA61K31/7088A61K47/549

Quick answer

US patent 11000600 (Exon skipping oligomer conjugates for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/7088, A61K47/549, A61K47/645, A61K47/6807